← Eichor
Study identifier: NCT07222787 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes

Condition: Radiculopathy Lumbar · Degenerative Lumbar Disc Disease  ·  Sponsor: Providence Medical Technology, Inc.

PhaseNA
Planned participants250
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to assess the safety and effectiveness of the study device, CORUS-LX, as an adjunct to lumbar interbody fusion, when used in combination with pedicle screw and rod constructs for the treatment of lumbosacral degenerative disease in patients requiring 2 level (L4-S1) lumbar fusion, for the treatment of symptomatic degenerative lumbosacral disc disease. The main questions it aims to answer are: Is there fusion success at the treated posterior anatomy of each level? Is there an absence of major adverse device related events? Is there an absence of injections (steroid, facet joint, nerve block) or subsequent revision surgery at index levels for symptoms related to back or leg pain? Researchers will compare a control arm to the treatment arm to see if research results vary from standard minimally invasive supplemental posterior fusion. Eligible participants will undergo one of the below interventions: * Two-level lumbar interbody fusion at L4-L5 \& L5-S1 segments, with supplemental posterior fusion performed using the study device, including pedicle screw and rod fixation. * Two-level lumbar interbody fusion at L4-L5 \& L5-S1 segments, with standard minimally invasive supplemental posterior fusion including pedicle screw and rod fixation. Participants will also be asked to read, understand, and sign the informed consent, attend a Screening/Baseline visit, undergo surgery for their designated intervention, and participate in 5 additional stud…

This description comes directly from the study's public registry record.

Talk to the study team

Erik M Summerside, PhD  ·  (415) 923-9376  ·  ILIF@providencemt.com

Always discuss trial participation with your own doctor first.

Locations (10)

Barrow Brain & SpineScottsdale, Arizona, United StatesRecruiting
HonorHealth NeurologyScottsdale, Arizona, United StatesRecruiting
California SpineLos Angeles, California, United StatesRecruiting
Golden State Orthopedics & SpineLos Gatos, California, United StatesRecruiting
Orthopaedic Spine InstituteHinsdale, Illinois, United StatesRecruiting
Hospital for Special SurgeryNew York, New York, United StatesRecruiting
Olympia Neurological InstituteAustin, Texas, United StatesNot Yet Recruiting
Spine Physician InstituteDallas, Texas, United StatesTerminated
American Neurospine InstituteFrisco, Texas, United StatesRecruiting
Huntsman SpineSalt Lake City, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07222787